Parametric Portfolio Associates’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Parametric Portfolio Associates’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,890	Closed	-$353K	–	3985
2020 Q2	$353K	Sell	5,890 -3,123	-35%	-$286K	﹤0.01%	3406
2020 Q1	$679K	Buy	9,013 +641	+8%	+$73.8K	﹤0.01%	2997
2019 Q4	$1.15M	Buy	8,372 +1,801	+27%	+$219K	﹤0.01%	2992
2019 Q3	$781K	Buy	6,571 +1,464	+29%	+$204K	﹤0.01%	3153
2019 Q2	$715K	Sell	5,107 -624	-11%	-$110K	﹤0.01%	3212
2019 Q1	$1.02M	Buy	5,731 +2,489	+77%	+$374K	﹤0.01%	3020
2018 Q4	$510K	Buy	+3,242	New	+$483K	﹤0.01%	3302

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Parametric Portfolio Associates's ORTX Position: Q3 2020 in Review

Parametric Portfolio Associates sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2020, closing a stake of 5,890 shares — an estimated $353K sold.

Parametric Portfolio Associates first reported a position in ORTX in Q4 2018 and held it in 7 quarters. The position peaked at $1.15M in Q4 2019. 72 funds tracked by Wall St. Rank hold ORTX as of Q3 2020.

Parametric Portfolio Associates reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Parametric Portfolio Associates sold 5,890 Orchard Therapeutics plc American Depositary Shares shares in Q3 2020, an estimated $353K.
Parametric Portfolio Associates first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 7 quarters.
Parametric Portfolio Associates's Orchard Therapeutics plc American Depositary Shares position peaked at $1.15M in Q4 2019.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2020.

Based on Parametric Portfolio Associates's 13F filing for Q3 2020, filed 12 Nov 2020.